Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trialPaul R. Kalra, Claes Christian Strom, John G.F. Cleland et al.|The Lancet|2022Cited by 367
The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart ‘OMics’ in AGEing (HOMAGE) randomized clinical trialJohn G.F. Cleland, Theis Lange, Franco Cosmi et al.|European Heart Journal|2020Cited by 143
Effect of Semaglutide on Cardiac Structure and Function in Patients With Obesity-Related Heart FailureScott D. Solomon, Mikhail Kosiborod, John W. Ostrominski et al.|Journal of the American College of Cardiology|2024Cited by 113
Strategies to enhance recruitment of female participants to cardiovascular research: a joint British Cardiovascular Societies’ consensus document in collaboration with the British Heart Foundation Clinical Research CollaborativeVijay Kunadian, G. André Ng, Graziella Pompei et al.|Heart|2025Cited by 7